Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Ireland / NCT07908290
Recruiting Not applicable

Shower Gel and Participant-Reported Post-Exercise Soreness in Regular Exercisers

NCT07908290 · tracked via the Priya Life Science Ireland tracker
Sponsor
The Humanix
Phase
Not applicable
Started
2026-11
Last updated
2026-11-02

Condition(s) studied

Post-Exercise RecoveryMuscle Soreness

Investigational drug(s) / intervention(s)

Topical shower gelComparator

Topical shower gel: Topical shower gel containing a proprietary blend of active ingredients applied to the affected muscle groups experiencing soreness after a HYROX exercise session

Comparator: Generic, widely available shower gel with no active ingredients applied to the affected muscle groups after a HYROX exercise session

Study summary

The objective of this study is to evaluate any potential claims for a topical shower gel product about perceived recovery and other aspects of user experience and consumer satisfaction following HYROX exercise training.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Adults aged 18-65 years. * Regular exercisers capable of safely completing the relevant exercise session. * Able to understand the participant information and provide informed consent. * Able and willing to follow product-use instructions and complete the 24h, 48h and 72h follow-up forms. * Must be fluent in written and spoken English Exclusion Criteria: * Pregnancy, breastfeeding, or planning pregnancy during the study period. * Known relevant allergy or sensitivity to topical shower/bath/skincare products or study ingredients disclosed for safety screening. * Broken, inflamed or irritated skin in intended application areas. * Current injury, illness or condition making the exercise session unsafe or likely to materially confound perceived soreness/recovery outcomes. * Recent strenuous exercise, analgesic/NSAID use, or recovery interventions where the protocol-defined exclusion/restriction criteria are met. * Any other condition which, in the PI's judgement, makes participation inappropriate or unsafe.

Primary outcome measure(s)

  • Numerical Rating Scale (NRS) for muscle soreness — Baseline (pre-exercise), immediate post-exercise, 24 hours, 48 hours (primary endpoint), and 72 hours post-exercise.
    Adjusted between-group mean difference in 0-10 perceived muscle soreness Numerical Rating Scale (NRS) at 48 hours post-exercise (measured after the second product application / before the third application). Evaluated via ANCOVA model adjusting for immediate post-exercise/pre-application soreness, sex, and age. Scale ranges from 0 (no soreness at all) to 10 (worst possible soreness), where lower scores represent a better outcome.

Trial sites (1)

FacilityCityRegionStatus
Oak Gym, Dundalk Dublin Ireland Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07908290 on ClinicalTrials.gov ↗ ← All trials in Ireland